|
SKP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.14429618295276E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.87789800271321E-11 |
| Normal-vs-Stage2 |
4.920700E-03 |
| Normal-vs-Stage3 |
5.95119999999838E-05 |
| Normal-vs-Stage4 |
2.268200E-01 |
| Stage1-vs-Stage2 |
4.035400E-01 |
| Stage1-vs-Stage3 |
4.565000E-01 |
| Stage1-vs-Stage4 |
7.916000E-02 |
| Stage2-vs-Stage3 |
8.644400E-01 |
| Stage2-vs-Stage4 |
4.050600E-01 |
| Stage3-vs-Stage4 |
2.444200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95840027422878E-11 |
| Normal-vs-AfricanAmerican |
1.721500000329E-07 |
| Normal-vs-Asian |
1.458420E-03 |
| Caucasian-vs-AfricanAmerican |
2.564600E-01 |
| Caucasian-vs-Asian |
9.289800E-01 |
| AfricanAmerican-vs-Asian |
7.302600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.31346061699378E-12 |
| Normal-vs-Female |
1.989040E-04 |
| Male-vs-Female |
8.017800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79288999999638E-05 |
| Normal-vs-Extreme_Weight |
1.03969999276643E-09 |
| Normal-vs-Obese |
1.79610000206054E-08 |
| Normal-vs-Extreme_Obese |
2.77129999948222E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.016000E-01 |
| Normal_Weight-vs-Obese |
9.123600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.689220E-01 |
| Extreme_Weight-vs-Obese |
4.901800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.698000E-01 |
| Obese-vs-Extreme_Obese |
9.524400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.37270000000189E-06 |
| Normal-vs-Age(41-60Yrs) |
3.32459999530244E-08 |
| Normal-vs-Age(61-80Yrs) |
5.86786175205134E-12 |
| Normal-vs-Age(81-100Yrs) |
3.9428000000008E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.878200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.923000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.783200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.817500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.925400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.06374933703546E-12 |
| Normal-VS-Type2 PRCC |
7.2952999996545E-07 |
| Normal-VS-KIRP CIMP |
1.133720E-02 |
| Normal-VS-Unclassified PRCC |
6.45420000000563E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.421700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.265400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.472000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.909400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.125000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.412800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6248000157002E-09 |
| Normal-vs-N1 |
6.936700E-03 |
| Normal-vs-N2 |
7.674200E-01 |
| N0-vs-N1 |
8.173900E-02 |
| N0-vs-N2 |
2.694300E-02 |
| N1-vs-N2 |
3.073000E-01 |
|
|
